TD Cowen on Amgen's (AMGN) Dazodalibep: 'An Overlooked Gem In Amgen's Pipeline?'
Tweet Send to a Friend
TD Cowen analyst Yaron Werber reiterated a Buy rating and $420.00 price target on Amgen (NASDAQ: AMGN).The analyst commented: "Dazodalibep ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
